Bill Summary

by Chaney Co Sponsors: Abbott, Amesty, Anderson, Baker, Bankson, Barnaby, Bartleman, Caruso, Cross, Garcia (A), Gonzalez Pittman, Gossett-Seidman, Gottlieb, Jacques, Joseph, Killebrew, Leek, Lopez (V), Massullo, MD, Melo, Salzman, Steele, Tuck, Waldron, Woodson, Bell CS Sponsors: Healthcare Regulation Subcommittee, Appropriations Committee, Health & Human Services Committee

Prescription Drugs: Requires drug manufacturers to notify DBPR of reportable drug price increases; prohibits manufacturers from claiming public records exemption for trade secrets for information provided in forms or reports; requires DFS to designate employee as primary contact on issues relating to PBMs; provides penalty for persons who do not hold certificate of authority to act as administrator; requires PBMs to identify ownership affiliations to office; provides requirements for contracts between PBM & participating pharmacy; provides for biennial examinations of PBMs. Effective Date: July 1, 2023

   H Healthcare Regulation Subcommittee
   H Appropriations Committee
   H Health & Human Services Committee